KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $589.0 million.

  • Gilead Sciences' Tax Provisions rose 29831.65% to $589.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 271904.76%. This contributed to the annual value of $211.0 million for FY2024, which is 8307.94% down from last year.
  • Gilead Sciences' Tax Provisions amounted to $589.0 million in Q3 2025, which was up 29831.65% from $468.0 million recorded in Q2 2025.
  • Gilead Sciences' 5-year Tax Provisions high stood at $852.0 million for Q3 2021, and its period low was -$315.0 million during Q1 2024.
  • Moreover, its 5-year median value for Tax Provisions was $383.0 million (2021), whereas its average is $325.0 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 30342.47% in 2024, then surged by 29831.65% in 2025.
  • Over the past 5 years, Gilead Sciences' Tax Provisions (Quarter) stood at $383.0 million in 2021, then grew by 3.92% to $398.0 million in 2022, then tumbled by 40.45% to $237.0 million in 2023, then soared by 62.45% to $385.0 million in 2024, then soared by 52.99% to $589.0 million in 2025.
  • Its Tax Provisions stands at $589.0 million for Q3 2025, versus $468.0 million for Q2 2025 and $334.0 million for Q1 2025.